Yousif Capital Management LLC Sells 5,736 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Yousif Capital Management LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% in the fourth quarter, HoldingsChannel reports. The firm owned 113,469 shares of the healthcare conglomerate’s stock after selling 5,736 shares during the period. UnitedHealth Group makes up about 0.7% of Yousif Capital Management LLC’s investment portfolio, making the stock its 13th biggest holding. Yousif Capital Management LLC’s holdings in UnitedHealth Group were worth $59,738,000 as of its most recent filing with the SEC.

A number of other hedge funds have also added to or reduced their stakes in UNH. International Assets Investment Management LLC increased its holdings in shares of UnitedHealth Group by 53,573.1% during the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after acquiring an additional 2,348,107 shares in the last quarter. Jennison Associates LLC boosted its position in shares of UnitedHealth Group by 49.3% during the fourth quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock valued at $1,904,670,000 after buying an additional 1,195,352 shares during the last quarter. Mawer Investment Management Ltd. boosted its position in shares of UnitedHealth Group by 75.0% during the third quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock valued at $1,014,002,000 after buying an additional 862,024 shares during the last quarter. California Public Employees Retirement System boosted its position in shares of UnitedHealth Group by 35.9% during the fourth quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock valued at $1,627,311,000 after buying an additional 815,822 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its position in shares of UnitedHealth Group by 20.1% during the third quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock valued at $1,879,245,000 after buying an additional 623,631 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 1.0 %

Shares of NYSE:UNH traded down $4.86 during trading on Tuesday, hitting $486.37. The stock had a trading volume of 3,645,655 shares, compared to its average volume of 4,543,351. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The company has a market capitalization of $448.40 billion, a PE ratio of 29.73, a PEG ratio of 1.38 and a beta of 0.54. The firm’s fifty day moving average is $487.49 and its 200 day moving average is $514.76. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same quarter last year, the company earned $6.26 EPS. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. Analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

Analyst Ratings Changes

UNH has been the topic of several research analyst reports. Wells Fargo & Company cut their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Stephens reissued an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Truist Financial reaffirmed a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research report on Friday. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $570.05.

Insider Buying and Selling

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.